SECdecoded › DGX
QUEST DIAGNOSTICS INC (DGX) insider trading
| PFEIFFER GARY M Director |
Open-market sale 10b5-1 planned size $••• · filed 2026-10-28 |
| CARTER ROBERT B Director |
Code L size $••• · filed 2026-10-23 |
| SAMAD SAM Executive Vice President & CFO |
Grant / award size $••• · filed 2026-10-23 |
| Gregg Vicky B Director |
Grant / award size $••• · filed 2026-10-23 |
| KUPPUSAMY KARTHIK SVP, Clinical Solutions |
Code L size $••• · filed 2026-10-23 |
| Lassiter Wright III Director |
Code L size $••• · filed 2026-10-23 |
| Plewman Patrick SVP for Diagnostic Services |
Code L size $••• · filed 2026-10-23 |
| MAIN TIMOTHY L Director |
Code L size $••• · filed 2026-10-23 |
| DELANEY MARK E SVP & Chief Commercial Officer |
Code L size $••• · filed 2026-10-23 |
| WENTWORTH TIMOTHY C Director |
Grant / award size $••• · filed 2026-10-02 |
| Davis J. E. CEO and President |
Open-market sale 10b5-1 planned size $••• · filed 2026-09-03 |
| PREVOZNIK MICHAEL E SVP & General Counsel |
Option exercise Open-market sale Gift 10b5-1 planned size $••• · filed 2026-08-31 |
Form 4s report every insider trade. The transaction type and whether it was a pre-arranged 10b5-1 plan are shown above — the exact dollar size and what it signals are in the full analysis.
See the size of every DGX insider trade — and whether that CEO sale was routine or a real decision — in plain English.
Open DGX in SECdecoded → Free account · plain-English AI analysis · no card required